Enhanced renal graft survival in HLA-A mismatched transplants.
Bućin
D
D
Blood Center, University Hospital, Lund, Sweden.
Ekberg
H
H
Lindholm
A
A
Persson
H
H
Tufvesson
G
G
Albrechtsen
D
D
D000328:Adult; D001379:Azathioprine / Q000008:administration & dosage; D001803:Blood Transfusion; D002102:Cadaver; D016572:Cyclosporine / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology* / Q000401:mortality / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D015234:HLA-A Antigens / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011183:Postoperative Complications / Q000276:immunology* / Q000401:mortality / Q000517:prevention & control; D016016:Proportional Hazards Models; D015996:Survival Rate
D015234:HLA-A Antigens; D016572:Cyclosporine; D001379:Azathioprine